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Background
The published quote of infections in 108 papers concern-
ing 24.436 shunt-treatments between 1959 and 1993
counts, with a decreasing trend, 8.7%. In three meta-anal-
yses (Haines, Langley, Aschoff 94) a systemic antibiotic
prophylaxis, that is standard since 20 years, showed some
effect, however, due to low local tissue concentrations and
insufficient penetration of the bacterial slime barrier in
current studies the improvement of infection rates stag-
nate at around 8% and rise up to 21.7% at children (Vin-
chon 03). An encouraging step was the development of
silicones with antibiotic impregnations (Bayston 89,
Kockro 00) in the late eighties. Catheters with 1%
Rifampin and Clindamycin are commercially available
since years (Codman BactiSeal®). Up to 2005 30.000 sets
were sold.
Materials and methods
In this study we did a retrospective evaluation of the infec-
tion rate of BactiSeal shunt-catheters at 48 patients (4 of
them < 18 years), who were estimated by the surgeons get-
ting infections with a higher risk, e.g. after systemic
inflammations or external CSF drainage.
Results
Five of 48 (higher-risk)-patients developed a shunt infec-
tion in the first year (10.4%).
Discussion
Surprisingly, in the literature we found two prospective
randomised studies with 82 patients concerning the use of
BactiSeal catheters, only (4.9% infections). In addition we
registered one sequential and two retrospective series, all
without randomisation; 268 patients showed a mean
quote of 2.6% (no-high risk patients). Inclusively of our
own data we summarized 398 BactiSeal-cases with an
infection rate of 4.0% (range 1.4–10.4%) that appeared,
compared to control groups without antibiotic impregna-
tion, as effective. But generally the statistic power of pub-
lished evaluations is very poor; they represent 0.27% of
30.000 sold units, only (status 2005).
Conclusion
The infection quote of BactiSeal-shunts in patients with
higher risks is about 7.5% (Will 02) resp. 10.4% (own
results). The cumulative quote of impregnated catheters
counts 4.0%, that may appear as improved compared to
standard experience with infection rates about 8%.
Nevertheless, randomised prospective studies are neces-
sary to prove the effect of antibiotic impregnated catheters
especially in patients with a higher risk of infection.
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